As of Wednesday, March 18, HCA’s lobby is closed. In-person customer services for Apple Health and the PEBB and SEBB Programs will not be available. Learn more.
Vertebroplasty, kyphoplasty and sacroplasty
Vertebroplasty, kyphoplasty and sacroplasty, (VKS) was first reviewed by the HTA program in 2011.
- In 2016, an update literature review of VKS research was conducted to determine if newly available evidence published since 2011 was likely to change the original coverage determination. The technology was not selected for re-review.
- In 2017, a supplement to the 2016 literature review was published. The technology was not selected for re-review.
Vertebroplasty involves injection of bone cement into a partially collapsed vertebral body, while kyphoplasty involves expansion of the partially collapsed vertebral body with an inflatable bone tamp, in an effort to relieve pain and provide stability. Sacroplasty involves surgical treatment that attempts to repair sacral insufficiency fractures using bone cement.
These surgical procedures are less invasive than other spinal surgical procedures, but more invasive than conservative medical therapy. Significant questions remain about the safety, efficacy and effectiveness (particularly long term and appropriate selection and therapy phase), and the cost effectiveness of vertebroplasty, kyphoplasty and sacroplasty.
Primary criteria ranking
- Safety = Medium
- Efficacy = Medium
- Cost = Medium
Documents (2017 update literature supplement)
Document (2016 update literature)
Documents (2010 assessment)
- Final key questions
- Draft report: Peer review, public comment and response
- Final evidence report
- Final evidence report: appendices*
- Final findings and decision
* Due to file size, Appendix 2 is only available by request.
Assessment timeline (2010)
Draft report published: October 7, 2010
Public comment period: October 7 to October 22, 2010
Final report published: November 5, 2010
HTCC public meeting: December 10, 2010